Clinical Significance of CDH13 Promoter Methylation in Serum Samples From Patients With Bladder Transitional Cell Carcinoma

Journal of International Medical Research - United Kingdom
doi 10.1177/147323001103900119
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

The Expression and Clinical Significance of ZBTB7 in Transitional Cell Carcinoma of the Bladder

Oncology Letters
Cancer ResearchOncology
2017English

Clinical Significance of Aberrant DEUP1 Promoter Methylation in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

MicroRNA Profiling of Dogs With Transitional Cell Carcinoma of the Bladder Using Blood and Urine Samples

BMC Veterinary Research
MedicineVeterinary
2017English

DNA Methylation and the Mechanisms of CDKN2A Inactivation in Transitional Cell Carcinoma of the Urinary Bladder

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2000English

Transitional Cell Carcinoma of the Bladder in Pediatric Patients: Where Do We Stand?

Urologia Colombiana
Urology
2020English

Spontaneous Intraperitoneal Rupture of the Bladder in Association With Transitional Cell Carcinoma.

Postgraduate Medical Journal
Medicine
1988English

Penile Metastasis From Primary Transitional Cell Carcinoma of the Bladder Sparing the Urethra

Canadian Urological Association Journal
Urology
2016English

Peritoneal Carcinomatosis Due to Transitional Cell Carcinoma of the Bladder: CT Findings in Two Patients.

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1995English

AB168. Expression and Clinical Significance of CCAT2 in Renal Cell Carcinoma and Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy